Coburn JW - Search Results

1

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.

Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA, Drüeke TB, Cunningham J, Sherrard DJ, McCary LC, Olson KA, Turner SA, Martin KJ. Moe SM, et al. Among authors: coburn jw. Kidney Int. 2005 Feb;67(2):760-71. doi: 10.1111/j.1523-1755.2005.67139.x. Kidney Int. 2005. PMID: 15673327 Free article. Clinical Trial.

2

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.

Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, Blaisdell PW, Brenner RM, Turner SA, Martin KJ. Lindberg JS, et al. Among authors: coburn jw. Kidney Int. 2003 Jan;63(1):248-54. doi: 10.1046/j.1523-1755.2003.00720.x. Kidney Int. 2003. PMID: 12472790 Free article. Clinical Trial.

3

A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism.

Goodman WG, Frazao JM, Goodkin DA, Turner SA, Liu W, Coburn JW. Goodman WG, et al. Among authors: coburn jw. Kidney Int. 2000 Jul;58(1):436-45. doi: 10.1046/j.1523-1755.2000.00183.x. Kidney Int. 2000. PMID: 10886592 Free article. Clinical Trial.

4

Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis.

Charytan C, Coburn JW, Chonchol M, Herman J, Lien YH, Liu W, Klassen PS, McCary LC, Pichette V. Charytan C, et al. Among authors: coburn jw. Am J Kidney Dis. 2005 Jul;46(1):58-67. doi: 10.1053/j.ajkd.2005.04.013. Am J Kidney Dis. 2005. PMID: 15983958 Clinical Trial.

5

An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.

Malluche HH, Monier-Faugere MC, Wang G, Frazã O JM, Charytan C, Coburn JW, Coyne DW, Kaplan MR, Baker N, McCary LC, Turner SA, Goodman WG. Malluche HH, et al. Among authors: coburn jw. Clin Nephrol. 2008 Apr;69(4):269-78. doi: 10.5414/cnp69269. Clin Nephrol. 2008. PMID: 18397701 Clinical Trial.

6

The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism.

Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, Barri YM, Cohen RM, Coburn JW. Goodman WG, et al. Among authors: coburn jw. J Am Soc Nephrol. 2002 Apr;13(4):1017-1024. doi: 10.1681/ASN.V1341017. J Am Soc Nephrol. 2002. PMID: 11912261 Clinical Trial.

7

Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia.

Kraut JA, Shinaberger JH, Singer FR, Sherrard DJ, Saxton J, Miller JH, Kurokawa K, Coburn JW. Kraut JA, et al. Among authors: coburn jw. Kidney Int. 1983 May;23(5):725-30. doi: 10.1038/ki.1983.85. Kidney Int. 1983. PMID: 6876568 Free article.

8

Calcium-sensing receptor and calcimimetic agents.

Coburn JW, Elangovan L, Goodman WG, Frazaõ JM. Coburn JW, et al. Kidney Int Suppl. 1999 Dec;73:S52-8. doi: 10.1046/j.1523-1755.1999.07303.x. Kidney Int Suppl. 1999. PMID: 10633465 Free article. Review.

9

Bone histologic response to deferoxamine in aluminum-related bone disease.

Andress DL, Nebeker HG, Ott SM, Endres DB, Alfrey AC, Slatopolsky EA, Coburn JW, Sherrard DJ. Andress DL, et al. Among authors: coburn jw. Kidney Int. 1987 Jun;31(6):1344-50. doi: 10.1038/ki.1987.148. Kidney Int. 1987. PMID: 2441107 Free article.

10

Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.

Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG. Salusky IB, et al. Among authors: coburn jw. Kidney Int. 1988 May;33(5):975-82. doi: 10.1038/ki.1988.96. Kidney Int. 1988. PMID: 3392886 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters